Target intelligence / Profile preview

Alpha-adrenergic receptor alpha-1 and alpha-2 subtypes (α1A, α1B, α1D, α2A, α2B, α2C)

Target
α1A, α1B, α1D, α2A, α2B, α2C
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Alpha-adrenergic receptors are a class of G protein-coupled receptors that mediate the effects of catecholamines (primarily norepinephrine and epinephrine) in the sympathetic nervous system. There are two major types with multiple subtypes: Alpha-1 (α1A, α1B, α1D) receptors are primarily responsible for smooth muscle contraction and vasoconstriction, while Alpha-2 (α2A, α2B, α2C) receptors are involved in feedback inhibition of neurotransmitter release and can influence vascular tone and central nervous system functions. These receptors are prominent targets for drugs treating hypertension, urinary retention, psychiatric disease, and more, with distinct pharmacological profiles depending on subtype selectivity.

Other names
Alpha-adrenergic receptoradrenergic alpha receptoralpha-adrenoceptorα-adrenoceptorα1Aα1Bα1Dα2Aα2Bα2C
02

Mechanism of action

Agonists stimulate the receptors to induce downstream signaling (α1: Gq-phospholipase C/calcium mobilization; α2: Gi-inhibition of adenylyl cyclase, lowers cAMP). Antagonists block receptor activity, leading to vasodilation (α1 blockers) or increased neurotransmitter release (α2 blockers).

03

Biological functions

Signal transductionRegulation of vascular tone (vasoconstriction/vasodilation)Modulation of neurotransmitter releaseRegulation of smooth muscle contractionInfluences on cardiac output and heart rate
04

Disease associations

Cardiovascular disease (hypertension, heart failure, shock)Urological disease (benign prostatic hyperplasia)Neuropsychiatric disordersAddiction (involvement in central pathways)Pain and analgesia
05

Safety considerations

Orthostatic hypotension (with α1 blockers)Reflex tachycardiaSedation or depression (with α2 agonists)Nasal congestion, dizziness, sexual dysfunction
06

Interacting drugs

phenylephrine

12 more in the full profile.

07

Biomarkers

No widely used direct biomarkers, but receptor expression/polymorphisms are studied in research for cardiovascular and psychiatric risk

Beyond the preview

Go deeper on Alpha-adrenergic receptor alpha-1 and alpha-2 subtypes (α1A, α1B, α1D, α2A, α2B, α2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-adrenergic receptor alpha-1 and alpha-2 subtypes (α1A, α1B, α1D, α2A, α2B, α2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call